Pure and Applied Chemistry

Pure Appl. Chem., 2010, Vol. 82, No. 8, pp. 1635-1645

http://dx.doi.org/10.1351/PAC-CON-09-10-44

Published online 2010-06-08

Body-on-a chip: Using microfluidic systems to predict human responses to drugs

References

• 1. I. Kola, J. Landis. Nat. Rev. Drug Discovery 3, 711 (2004).
• 2. B. Hughes. Nat. Rev. Drug Discovery 8, 93 (2009). (http://dx.doi.org/10.1038/nrd2813)
• 3. J. H. Sung, M. L. Shuler. Bioprocess Biosyst. Eng. 33, 5 (2010). (http://dx.doi.org/10.1007/s00449-009-0369-y)
• 4. L. E. Gerlowski, R. K. Jain. J. Pharm. Sci. 72, 1103 (1983). (http://dx.doi.org/10.1002/jps.2600721003)
• 5. L. M. Sweeney, M. L. Shuler, J. G. Babish, A. Ghanem. Toxicol. in Vitro 9, 307 (1995). (http://dx.doi.org/10.1016/0887-2333(95)00007-U)
• 6. A. Sin, K. C. Chin, M. F. Jamil, Y. Kostov, G. Rao, M. L. Shuler. Biotechnol. Prog. 20, 338 (2004). (http://dx.doi.org/10.1021/bp034077d)
• 7. D. H. Freedman. Newsweek CXLV1:59 (Oct. 10, 2005).
• 8. D. A. Tatosian, M. L. Shuler. Biotechnol. Bioeng. 103, 187 (2009). (http://dx.doi.org/10.1002/bit.22219)
• 9. J. H. Sung, M. L. Shuler. Lab Chip 9, 1385 (2009). (http://dx.doi.org/10.1039/b901377f)
• 10. K. Viravaidya, A. Sin, M. L. Shuler. Biotechnol. Prog. 20, 316 (2004). (http://dx.doi.org/10.1021/bp0341996)
• 11. K. Viravaidya, M. L. Shuler. Biotechnol. Prog. 20, 590 (2004). (http://dx.doi.org/10.1021/bp034238d)
• 12. N. Korin, A. Bransky, U. Dinnar, S. Levenberg. Lab Chip 7, 611 (2007). (http://dx.doi.org/10.1039/b702392h)
• 13. P. Chao, T. Maguire, E. Novik, K.-C. Cheng, M. L. Yarmush. Biochem. Pharmacol. 78, 625 (2009). (http://dx.doi.org/10.1016/j.bcp.2009.05.013)
• 14. M. C. Cushing, K. S. Anseth. Science 316, 1133 (2007). (http://dx.doi.org/10.1126/science.1140171)
• 15. J. H. Sung, J. R. Choi, D. H. Kim, M. L. Shuler. Biotechnol. Bioeng. 104, 516 (2009). (http://dx.doi.org/10.1002/bit.22413)
• 16. A. Ghanem, M. L. Shuler. Biotechnol. Prog. 16, 334 (2000). (http://dx.doi.org/10.1021/bp9901522)
• 17. J. H. Sung, M. L. Shuler. Biomed. Microdevices 11, 731 (2009). (http://dx.doi.org/10.1007/s10544-009-9286-8)
• 18. H. Xu, W. L. Kraus, M. L. Shuler. Biotechnol. Bioeng. 101, 1276 (2008). (http://dx.doi.org/10.1002/bit.21991)
• 19. J. Z. Xing, L. Zhu, S. Gabos, L. Xie. Toxicol. in Vitro 20, 995 (2006). (http://dx.doi.org/10.1016/j.tiv.2005.12.008)
• 20. A. Natarajan, P. Molnar, K. Sieverdes, A. Jamshidi, J. Hickman. Toxicol. in Vitro 20, 375 (2006). (http://dx.doi.org/10.1016/j.tiv.2005.08.014)
• 21. F. Asphahani, M. Zhang. Analyst 132, 835 (2007). (http://dx.doi.org/10.1039/b704513a)
• 22. T. I. Oh, J. H. Sung, D. A. Tatosian, M. L. Shuler, D. Kim. Cytometry A 71, 857 (2007).
• 23. D. A. Tatosian, M. L. Shuler, D. Kim. Opt. Lett. 30, 1689 (2005). (http://dx.doi.org/10.1364/OL.30.001689)
• 24. C. Pascaud, M. Garrigos, S. Orlowski. Biochem. J. 333, 351 (1998).
• 25. M. Lehnert, W. S. Dalton, D. Roe, S. Emerson, S. E. Salmon. Blood 77, 348 (1991).
• 26. D. Powell. Am. J. Physiol. 241, G275 (1981).
• 27. J. J. Powell, M. W. Whitehead, S. Lee, R. P. H. Thompson. Food Chem. 51, 381 (1994). (http://dx.doi.org/10.1016/0308-8146(94)90189-9)
• 28. M. M. Doherty, W. M. Charman. Clin. Pharmacokinet. 41, 235 (2002). (http://dx.doi.org/10.2165/00003088-200241040-00001)
• 29. H. P. Rang, M. M. Dale, J. M. Ritter. Pharmacology, 4^th ed., Churchill Livingston, Edinburgh (1999).
• 30. A. Wikman-Larhed, P. Arthurson. Eur. J. Pharm. Sci. 3, 171 (1995). (http://dx.doi.org/10.1016/0928-0987(95)00007-Z)
• 31. E. Walter, S. Januch, B. J. Roessler, J. M. Hilfinger, G. L. Amidon. J. Pharm. Sci. 85, 1070 (1996). (http://dx.doi.org/10.1021/js960110x)
• 32. C. Hilgendorf, H. Spahn-Langguth, C. G. Regardh, E. Lipka, G. L. Amidon, P. Langguth. J. Pharm. Sci. 89, 63 (2000). (http://dx.doi.org/10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6)
• 33. P. Artursson, K. Palm, K. Luthman. Adv. Drug Delivery Rev. 46, 27 (2001). (http://dx.doi.org/10.1016/S0169-409X(00)00128-9)
• 34. J. F. Forstner, G. G. Forstner. “Gastrointestinal mucus”, in Physiology of the Gastronintestinal Tract, 3^rd ed., L. R. Johnson (Ed.), pp. 1255–1283, Raven Press, New York (1994).
• 35. A. Wikman, J. Karlsson, I. Carlstedt, P. Arturrson. Pharm. Res. 10, 843 (1993). (http://dx.doi.org/10.1023/A:1018905109971)
• 36. M. E. Conrad, J. N. Umbreit, E. G. Moore. J. Am. Coll. Nutr. 12, 720 (1993).
• 37. M. E. Conrad, J. N. Umbreit, E. G. Moore. Adv. Exp. Med. Biol. 356, 69 (1994).
• 38. G. J. Mahler, M. L. Shuler, R. P. Glahn, J. Nutr. Biochem. 20, 494 (2009). (http://dx.doi.org/10.1016/j.jnutbio.2008.05.006)
• 39. S. H. Choi, M. Nishikawa, A. Sakoda, Y. Sakai. Toxicol. in Vitro 18, 393 (2004). (http://dx.doi.org/10.1016/j.tiv.2003.09.010)
• 40. S. H. Choi, O. Fukuda, A. Sakoda, Y. Sakai. Mater. Sci. Eng., C 24, 333 (2004). (http://dx.doi.org/10.1016/j.msec.2003.12.002)
• 41. M. R. Brand, T. L. Hannah, C. Mueller, Y. Cetin, F. G. Hamel. Ann. Biomed. Eng. 28, 1210 (2000). (http://dx.doi.org/10.1114/1.1318926)
• 42. G. J. Mahler, M. B. Esch, R. P. Glahn, M. L. Shuler. Biotechnol. Bioeng. 104, 193 (2009). (http://dx.doi.org/10.1002/bit.22366)
• 43. J. S. Gujral, T. R. Knight, A. Farhood, M. L. Bajt, H. Jaeschke. Toxicol. Sci. 67, 322 (2002). (http://dx.doi.org/10.1093/toxsci/67.2.322)
• 44. B. H. Stewart, O. H. Chan, R. H. Lu, E. L. Reyner, H. L. Schmid, H. W. Hamilton, B. A. Steinbaugh, M. D. Taylor. Pharm. Res. 12, 693 (1995). (http://dx.doi.org/10.1023/A:1016207525186)
• 45. G. J. Mahler, M. L. Shuler, R. P. Glahn. J. Nutr. Biochem. 20, 494 (2009). (http://dx.doi.org/10.1016/j.jnutbio.2008.05.006)
• 46. V. M. Weaver, O. W. Petersen, F. Wang, C. A. Larabell, P. Briand, C. Damsky, M. J. Bissell. J. Cell Biol. 137, 231 (1997). (http://dx.doi.org/10.1083/jcb.137.1.231)
• 47. J. H. Sung, C. Kam, M. L. Shuler. Lab Chip 10, 446 (2010). (http://dx.doi.org/10.1039/b917763a)
• 48. P. M. van Midwoud, G. M. M. Groothuis, M. T. Merema, E. Verpoorte. Biotechnol. Bioeng. 105, 184 (2010). (http://dx.doi.org/10.1002/bit.22516)